Cargando…

Enhanced liver Fibrosis® test predicts liver-related outcomes in the general population

BACKGROUND & AIMS: The Enhanced Liver Fibrosis® (ELF) test exhibits good discriminative performance in detecting advanced liver fibrosis and in predicting liver-related outcomes in patients with specific liver diseases, but large population-based studies are missing. We analysed the predictive p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saarinen, Kustaa, Färkkilä, Martti, Jula, Antti, Erlund, Iris, Vihervaara, Terhi, Lundqvist, Annamari, Åberg, Fredrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276292/ https://www.ncbi.nlm.nih.gov/pubmed/37333973 http://dx.doi.org/10.1016/j.jhepr.2023.100765

Ejemplares similares

Comparison of various strategies to define the optimal target population for liver fibrosis screening: A population‐based cohort study
por: Åberg, Fredrik, et al.
Publicado: (2022)

Serum lipopolysaccharides predict advanced liver disease in the general population
por: Männistö, Ville, et al.
Publicado: (2019)

Waist-hip ratio is superior to BMI in predicting liver-related outcomes and synergizes with harmful alcohol use
por: Åberg, Fredrik, et al.
Publicado: (2023)

Insulin Resistance and Genetic Risk Predict Liver‐Related Outcomes and Death in Nonalcoholic Fatty Liver Disease
por: Danford, Christopher J., et al.
Publicado: (2019)

Association between arterial hypertension and liver outcomes using polygenic risk scores: a population-based study
por: Åberg, Fredrik, et al.
Publicado: (2022)

A Dynamic Aspartate‐to‐Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease
por: Åberg, Fredrik, et al.
Publicado: (2021)

Effects of altered salt intake and diet on cytokines in humans: A 20‐week randomized cross‐over intervention study
por: Niiranen, Teemu, et al.
Publicado: (2022)

The Performance of Enhanced Liver Fibrosis (ELF) Test for the Staging of Liver Fibrosis: A Meta-Analysis
por: Xie, Qingsong, et al.
Publicado: (2014)

Repeated measurements of non‐invasive fibrosis tests to monitor the progression of non‐alcoholic fatty liver disease: A long‐term follow‐up study
por: Balkhed, Wile, et al.
Publicado: (2022)

Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
por: Younossi, Zobair M., et al.
Publicado: (2021)

Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients
por: Soto, Marcelo, et al.
Publicado: (2017)

The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease
por: Trembling, Paul M., et al.
Publicado: (2020)

Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
por: Heo, Ja Yoon, et al.
Publicado: (2018)

Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection
por: Trembling, P M, et al.
Publicado: (2014)

Oral Health and Liver Disease: Bidirectional Associations—A Narrative Review
por: Åberg, Fredrik, et al.
Publicado: (2022)

A Novel Fibrosis Index Comprising a Non-Cholesterol Sterol Accurately Predicts HCV-Related Liver Cirrhosis
por: Ydreborg, Magdalena, et al.
Publicado: (2014)

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
por: Graupera, Isabel, et al.
Publicado: (2022)

Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis
por: Boyd, Sonja, et al.
Publicado: (2017)

Chronic cholestasis detection by a novel tool: automated analysis of cytokeratin 7-stained liver specimens
por: Sjöblom, Nelli, et al.
Publicado: (2021)

Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
por: Graupera, Isabel, et al.
Publicado: (2023)

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)
por: Poynard, Thierry, et al.
Publicado: (2010)

Liver fibrosis in patients with chronic liver diseases: are laboratory tests useful to diagnosis?
por: Leonardi, Salvatore, et al.
Publicado: (2011)

TSH Levels as an Independent Risk Factor for NAFLD and Liver Fibrosis in the General Population
por: Martínez-Escudé, Alba, et al.
Publicado: (2021)

Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?
por: Canivet, Clémence M., et al.
Publicado: (2022)

The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study
por: Connoley, Declan, et al.
Publicado: (2021)

Biopsy-Controlled Liver Fibrosis Staging Using the Enhanced Liver Fibrosis (ELF) Score Compared to Transient Elastography
por: Wahl, Kristin, et al.
Publicado: (2012)

Limitations of non-invasive tests for assessment of liver fibrosis
por: Patel, Keyur, et al.
Publicado: (2020)

OSBP-Related Protein 8 (ORP8) Regulates Plasma and Liver Tissue Lipid Levels and Interacts with the Nucleoporin Nup62
por: Zhou, Tianhong, et al.
Publicado: (2011)

Improved Precision-Cut Liver Slice Cultures for Testing Drug-Induced Liver Fibrosis
por: Dewyse, Liza, et al.
Publicado: (2022)

The association between anthropometric measures and glycated haemoglobin (HbA1c) is different in Russian, Somali and Kurdish origin migrants compared with the general population in Finland: a cross-sectional population-based study
por: Skogberg, Natalia, et al.
Publicado: (2019)

Fish oil and krill oil differentially modify the liver and brain lipidome when fed to mice
por: Skorve, Jon, et al.
Publicado: (2015)

Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials
por: Huh, Jimi, et al.
Publicado: (2019)

Association between reactive oxygen species production in neutrophils and liver fibrosis in the general population
por: Sato, Satoshi, et al.
Publicado: (2023)

High prevalence of liver fibrosis among general population: a Romanian population-based study
por: Trifan, Anca, et al.
Publicado: (2023)

Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B
por: Park, Mi Sung, et al.
Publicado: (2013)

Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Personalized management of cirrhosis by non-invasive tests of liver fibrosis
por: Wong, Grace Lai-Hung, et al.
Publicado: (2015)

Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
por: Han, Ma Ai Thanda
Publicado: (2020)

Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis
por: Gan, Can, et al.
Publicado: (2022)

Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population
por: Kirino, Sakura, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rp07rns32kd4jvfo1r2b9rqv1l